Follow-up after radiological intervention in oncology: ECIO-ESOI evidence and consensus-based recommendations for clinical practice Guidelines


Authors: Maas, M.; Beets-Tan, R.; Gaubert, J. Y.; Gomez Munoz, F.; Habert, P.; Klompenhouwer, L. G.; Vilares Morgado, P.; Schaefer, N.; Cornelis, F. H.; Solomon, S. B.; van der Reijd, D.; Bilbao, J. I.
Title: Follow-up after radiological intervention in oncology: ECIO-ESOI evidence and consensus-based recommendations for clinical practice
Abstract: Interventional radiology plays an important and increasing role in cancer treatment. Follow-up is important to be able to assess treatment success and detect locoregional and distant recurrence and recommendations for follow-up are needed. At ECIO 2018, a joint ECIO-ESOI session was organized to establish follow-up recommendations for oncologic intervention in liver, renal, and lung cancer. Treatments included thermal ablation, TACE, and TARE. In total five topics were evaluated: ablation in colorectal liver metastases (CRLM), TARE in CRLM, TACE and TARE in HCC, ablation in renal cancer, and ablation in lung cancer. Evaluated modalities were FDG-PET-CT, CT, MRI, and (contrast-enhanced) ultrasound. Prior to the session, five experts were selected and performed a systematic review and presented statements, which were voted on in a telephone conference prior to the meeting by all panelists. These statements were presented and discussed at the ECIO-ESOI session at ECIO 2018. This paper presents the recommendations that followed from these initiatives. Based on expert opinions and the available evidence, follow-up schedules were proposed for liver cancer, renal cancer, and lung cancer. FDG-PET-CT, CT, and MRI are the recommended modalities, but one should beware of false-positive signs of residual tumor or recurrence due to inflammation early after the intervention. There is a need for prospective preferably multicenter studies to validate new techniques and new response criteria. This paper presents recommendations that can be used in clinical practice to perform the follow-up of patients with liver, lung, and renal cancer who were treated with interventional locoregional therapies. © 2020, The Author(s).
Keywords: cancer chemotherapy; treatment response; overall survival; cancer recurrence; cancer risk; cancer staging; nuclear magnetic resonance imaging; follow up; diagnostic accuracy; clinical practice; progression free survival; computer assisted tomography; tumor volume; lung cancer; oncology; cancer therapy; cancer mortality; intervention study; liver; systematic review; contrast enhancement; tumor recurrence; echography; fluorodeoxyglucose f 18; interventional radiology; cryoablation; diffusion weighted imaging; meta analysis; predictive value; recommendations; single photon emission computed tomography; fine needle aspiration biopsy; contrast-enhanced ultrasound; radioembolization; human; article; positron emission tomography-computed tomography; microwave thermotherapy
Journal Title: Insights into Imaging
Volume: 11
ISSN: 1869-4101
Publisher: SpringerOpen  
Date Published: 2020-01-01
Start Page: 83
Language: English
DOI: 10.1186/s13244-020-00884-5
PROVIDER: scopus
PMCID: PMC7366866
PUBMED: 32676924
DOI/URL:
Notes: Article -- Export Date: 3 August 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Stephen Solomon
    424 Solomon